CHEUNG ANTHONY TZEYEW
Known title: Chief Technology OfficerCIK: 0001998684
Associated companies
Transaction History
| ENGN | ▲ Buy | Option Exercise | 52,940 | $47K | 3/18/2024 | View on chart |
| ENGN | ▲ Buy | Grant | 49,933 | — | 10/31/2023 | View on chart |
| ENGN | ▲ Buy | Option Exercise | 52,940 | $47K | 3/18/2024 | View on chart |
| ENGN | ▲ Buy | Grant | 49,933 | — | 10/31/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
enGene to Host KOL Webinar on Oct 15, 2026
enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.
enGene to Host KOL Webinar on Oct 15, 2026. enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.